Integrating best practices in AI, genomics, cell culture, and laboratory techniques together contribute to protein expression success.

Beyond manufacturing capacity, sponsors seek expertise in specialized drug formulations, regulatory affairs, and service ...

As a result, there is a need for continued innovation and increased efficiency in terms of drug development to manage cost ... between entities. “Cell therapy research has been built on ...

Ladies and gentlemen, good morning and welcome to the Taysha Gene Therapies Full Year 2024 Conference Call. At this time all participants are in listen-only mode. A brief question-and-answer session ...

Whether autologous or allogeneic, manufacturing a cell therapy is much more complicated ... manufacturing, and control (CMC) as their efficacy data. And there are big questions about how these ...

Q4 2024 Results Conference Call February 26, 2025 11:00 AM ETCompany ParticipantsPeter Vozzo - ICR Healthcare, IRStacy Lindborg ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Phase 3 Ovarian Cancer Trial to Initiate in March 2025 Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial ...

Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that it has entered into a Master Services Collaboration Agreement with ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its breakthrough approach, Fuse Vectors aims to be the universal solution for AAV ...

This collaboration will extend to all aspects of cell therapy manufacturing including Chemistry, Manufacturing and Controls (CMC), Quality ... process development and BSB’s development of ...

Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that ...